about
Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonanceMyocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis.Transesophageal echocardiographic evaluation during aortic valve repair surgery.Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance taggingImaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology.Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.Repair of bicuspid aortic valves in patients with aortic regurgitation.Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion databaseCorrelation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting.Aortic valve area assessment: multidetector CT compared with cine MR imaging and transthoracic and transesophageal echocardiography.Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging.Insulin signalling in the heart.Evaluation of anatomic valve opening and leaflet morphology in aortic valve bioprosthesis by using multidetector CT: comparison with transthoracic echocardiography.Impact of left ventricular outflow tract ellipticity on the grading of aortic stenosis in patients with normal ejection fraction.Imaging the vulnerable plaque.EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.AMP-activated protein kinase in the control of cardiac metabolism and remodeling.The prevalence of cardiac dysfunction and the correlation with poor functioning among the very elderly.Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells.Prevalence and Prognostic Impact of Valve Area-Gradient Patterns in Patients ≥80 Years With Moderate-to-Severe Aortic Stenosis (from the Prospective BELFRAIL Study).Efficacy and safety of biodegradable polymer biolimus A9-eluting stent versus durable polymer everolimus-eluting stent in diabetic patients: a prospective non-randomized single-centre long-term comparison.Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol.Quantification of myocardial blood flow and assessment of its transmural distribution with real-time power modulation myocardial contrast echocardiography.Images and case reports in interventional cardiology. Thrombotic aortic restenosis after transapical Sapien valve implantation.Detection and quantification of myocardial scars by contrast-enhanced 3D echocardiography.Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation.Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography.Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community ConcerteInsulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides.Occupational exposure to cobalt is not associated with incipient signs of dilated cardiomyopathy in a Belgian refinery.Risk of valve-related events after aortic valve repair.Role of AMP-activated protein kinase in regulating hypoxic survival and proliferation of mesenchymal stem cells.Differential regulation of eEF2 and p70S6K by AMPKalpha2 in heart.The stimulation of heart glycolysis by increased workload does not require AMP-activated protein kinase but a wortmannin-sensitive mechanism.Heterogeneity of contrast effect during intermittent second harmonic myocardial contrast echocardiography in healthy patients.Value of adding natriuretic peptides and electrocardiographic findings to assess the presence of cardiac dysfunction in patients ≥80 years of age.Impact of preoperative symptoms on postoperative survival in severe aortic stenosis: implications for the timing of surgery.
P50
Q26824350-4F6CF22E-98EB-4D85-8E75-DCC58C5A7512Q28582345-EBC6C008-711F-48D0-AA1A-A9804D6DF5C2Q30439253-AC5F0F34-3A12-48CA-90FF-F463D66E8BE5Q31440633-3C682CE7-68C6-4B9D-AB85-D63600E9C370Q34118981-DA415CB6-32B9-459D-A63E-E316A072F9D4Q35027190-E5F6775F-018E-4F94-9F67-5CDFEC67B016Q35771926-ED17C803-C56E-46C1-A3CC-B5E273FD5019Q36248613-51A816AA-500B-4906-916D-A05E39875C81Q36527278-C04139A3-D32D-4C66-942A-ECED9271D768Q36687805-D4184B07-F09E-4C82-97D8-B8653E7B391AQ36847398-9ED31163-778A-48A7-9E92-694B6AF39172Q36881148-9563BECD-2BF0-4F71-864F-2D019936445BQ36935868-9F0094EC-F378-49E4-88A8-E44E9A6DE003Q37129268-80C077C0-C620-4341-A635-9B1D188912CBQ37658041-58D1BF3D-C9A2-4AB7-9613-7D9702495192Q37700790-8055C83E-3933-42AA-B5E7-C5F716F40C58Q37874805-4852FED1-ECD6-43DC-ADD5-4AB3D52D4D83Q37922310-2156A8CB-9CB1-46F0-B5B0-17A6CC34896AQ38024322-4625985A-D91A-4C7B-BF8C-1C084DC8768BQ38486409-3F132CE6-A867-4CC1-81CD-58DF9F1BB6B5Q39921277-7E3D10B6-14F1-4D59-BC53-AE99D85EDEF1Q40685585-8036D2F1-0CB7-4FFF-B203-46D9660DDD10Q41500514-B8D623E1-AAEF-4230-BA91-8A36FF3FD1C9Q42089705-A86B32E2-4812-4E52-985A-F9C343EF6F36Q42442164-1E922504-4FD9-4DE8-8F1A-808AC7FA5039Q42695931-83C74B89-E947-48C1-A774-F2FA902954F4Q43020478-D93EEB11-5D68-4614-A302-827599E42384Q43048111-0755FDD4-A401-405D-9CBB-F872460D8386Q43201824-08C4E262-18FB-4B79-840F-E9589789FC1FQ43630623-151E7191-E66E-4D21-89E7-8BBF182A6779Q43711411-0C49FD23-D07B-4BAA-94EF-43CD0EAB6644Q43750476-E0557A57-45FC-4701-A24C-C004738A0207Q43767906-2E900F6F-F235-486C-A4DB-D785A0434F30Q43792456-BFEE3706-D356-4CAE-9A9F-DD6566CCAA4CQ43848574-ABD7813F-4B73-42F3-9AB8-B89D2FD34ED0Q44008775-6BCD1FE3-136F-4503-964E-2AECB10899D8Q44205607-4CDCF67B-C70C-4382-AAA1-BDF7E5DE23A3Q44237795-87C60BD9-F5BA-4FE8-B924-688CC02C01D6Q44531765-27EE1454-E0CC-4B13-9F81-B36E86A93138Q44694858-A4C2C0D8-35E2-4C2F-BE13-70111C6E3CF8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jean-Louis Vanoverschelde
@ast
Jean-Louis Vanoverschelde
@en
Jean-Louis Vanoverschelde
@es
Jean-Louis Vanoverschelde
@nl
Jean-Louis Vanoverschelde
@sl
type
label
Jean-Louis Vanoverschelde
@ast
Jean-Louis Vanoverschelde
@en
Jean-Louis Vanoverschelde
@es
Jean-Louis Vanoverschelde
@nl
Jean-Louis Vanoverschelde
@sl
prefLabel
Jean-Louis Vanoverschelde
@ast
Jean-Louis Vanoverschelde
@en
Jean-Louis Vanoverschelde
@es
Jean-Louis Vanoverschelde
@nl
Jean-Louis Vanoverschelde
@sl
P106
P1153
19336371400
P21
P31
P496
0000-0002-8133-8913